TNGX (STOCKS)
Tango Therapeutics, Inc.
$21.000000
+1.050000 (+5.26%)
Prev close: $19.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Malte Peters
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,073.52M
- Employees
- 155
- P/E (TTM)
- -24.95
- P/B (TTM)
- 7.83
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $62.38M |
| Benefits Costs and Expenses | $163.97M |
| Costs And Expenses | $163.97M |
| Nonoperating Income/Loss | $9.70M |
| Operating Expenses | $173.67M |
| Research and Development | $132.17M |
| Other Operating Expenses | $41.51M |
| Operating Income/Loss | -$111.29M |
| Income/Loss From Continuing Operations After Tax | -$101.59M |
| Income/Loss From Continuing Operations Before Tax | -$101.59M |
| Income Tax Expense/Benefit | $4.00K |
| Interest Income/Expense After Provision For Losses | $5.63M |
| Interest Income/Expense Operating, Net | $5.63M |
| Net Income/Loss | -$101.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$101.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$101.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$0.87 |
| Diluted Earnings Per Share | -$0.87 |
| Basic Average Shares | 116,166,187 |
| Diluted Average Shares | 116,166,187 |
| Assets | $398.69M |
| Current Assets | $353.76M |
| Cash | $343.10M |
| Other Current Assets | $10.66M |
| Noncurrent Assets | $44.93M |
| Fixed Assets | $6.87M |
| Other Non-current Assets | $38.07M |
| Liabilities | $52.51M |
| Current Liabilities | $21.68M |
| Accounts Payable | $1.18M |
| Wages | $9.05M |
| Other Current Liabilities | $11.45M |
| Noncurrent Liabilities | $30.83M |
| Equity | $346.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $346.18M |
| Liabilities And Equity | $398.69M |
| Net Cash Flow From Operating Activities | -$138.89M |
| Net Cash Flow From Operating Activities, Continuing | -$138.89M |
| Net Cash Flow From Investing Activities | -$40.87M |
| Net Cash Flow From Investing Activities, Continuing | -$40.87M |
| Net Cash Flow From Financing Activities | $222.50M |
| Net Cash Flow From Financing Activities, Continuing | $222.50M |
| Net Cash Flow | $42.75M |
| Net Cash Flow, Continuing | $42.75M |
| Comprehensive Income/Loss | -$101.71M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$101.71M |
| Other Comprehensive Income/Loss | -$112.00K |